联合原代 CAR NK 细胞与放疗精准靶向横纹肌肉瘤
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.
69.3分
★★★☆☆
站内排序·非疗效
ALL SOURCES
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.
Natural Killer Cells in Paediatric Soft Tissue Sarcomas: A Systematic Review.
Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation.
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.
这些发现支持进一步开发 NK-92/5.28.z 细胞作为现货型免疫疗法用于治疗转移性 RMS。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。